首页> 外文期刊>Journal of Toxicologic Pathology >Concordance between Results of Medium-term Liver Carcinogenesis Bioassays and Long-term Findings for Carcinogenic 2-Nitropropane and Non-carcinogenic 1-Nitropropane in F344 Rats
【24h】

Concordance between Results of Medium-term Liver Carcinogenesis Bioassays and Long-term Findings for Carcinogenic 2-Nitropropane and Non-carcinogenic 1-Nitropropane in F344 Rats

机译:中期肝癌发生生物测定结果与F344大鼠致癌性2-硝基丙烷和非致癌性1-硝基丙烷的长期发现之间的一致性

获取原文
       

摘要

This study was conducted to determine the concordance of results for a pair of structural isomers, 2-nitropropane (2-NP) and 1-nitropropane (1-NP), using the rat medium-term liver carcinogenesis bioassay (Ito test) and previously published long-term carcinogenicity tests. Male F344 rats were given a single intraperitoneal injection of DEN (200 mg/kg b.w.) to initiate hepatocarcinogenesis. After 2 weeks, they received per os 0, 0.8, 4 or 20 mg/kg/day of 2-NP or 1-NP six times a week and were subjected to two-thirds partial hepatectomy at week 3. Non-initiated groups receiving 0 or 20 mg/kg/day were also included. The animals were sacrificed for quantitative analysis of GST-P-positive foci at week 8. With the highest dose of 2-NP, significantly increased numbers and areas of GST-P-positive foci were demonstrated as compared with the respective control but were not noted with 1-NP. In the non-DEN-initiated groups, many small GST-P-positive foci of less than 0.2 mm in diameter were also induced in the rats treated with 2-NP at 20 mg/kg/day but were lacking with 1-NP. These results strongly support that 2-NP is a complete hepatocarcinogen with a potent initiation activity, whereas 1-NP is not.
机译:这项研究是使用大鼠中期肝脏癌变生物测定法(伊藤试验)和以前进行的,以确定一对结构异构体2-硝基丙烷(2-NP)和1-硝基丙烷(1-NP)的结果是否一致。发表了长期致癌性测试。给雄性F344大鼠单次腹膜内注射DEN(200 mg / kg b.w.),以启动肝癌发生。 2周后,他们每周口服6、0、0.8、4或20 mg / kg / day的2-NP或1-NP,并在第3周接受三分之二的部分肝切除术。还包括0或20 mg / kg /天。在第8周处死动物以定量分析GST-P阳性灶。与相应的对照组相比,最大剂量的2-NP可显示GST-P阳性灶的数量和面积显着增加,但没有用1-NP表示。在非DEN引发的组中,在用20 mg / kg / day的2-NP治疗但缺乏1-NP的大鼠中,也诱发了许多直径小于0.2 mm的小GST-P阳性灶。这些结果强烈支持2-NP是具有有效起始活性的完整肝癌原,而1-NP则不是。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号